Most Recent
How to avoid experts ‘rolling on you’ and other expert evidence tips
Keeping experts in the loop and testing their evidence early is critical to avoiding common pitfalls with their evidence, according to solicitors.
Abbey Laboratories proves honest use of ‘Virkill’ trade mark
Animal health giant Abbey Laboratories has fought off a challenge to its bid to register 'Virkill' as a trade mark for its disinfectant products, despite an IP Australia delegate finding the name was deceptively similar to its opponent's 'Virukill' mark.
Settlement reached in fight over $100M in shares of data centre start-up Firmus
A settlement has been reached in a dispute over more than $100 million in shares in AI data centre start-up Firmus Grid ahead of an expected $7 billion IPO, just days before the company's founders were due to give evidence in court.
Firmus Grid directors to give evidence in $100M share dispute
The founders of AI data centre start-up Firmus Grid have been subpoenaed to give evidence in a dispute between former business partners Simon Raftery and Ben Madsen over $100 million in company shares, ahead of an expected $7 billion IPO.
Construction PRO
Bankruptcy trustee for developer Sam Fayad worries $8M loan a ‘sham’
The bankruptcy trustee for Dyldam Developments director Sam Fayad has raised concerns about upcoming sales of property in western Sydney, saying an $8 million loan secured against the real estate may be a "sham".
Construction PRO
Owners corporation loses bid to set aside Mercon DOCA
A judge has refused to set aside a deed of company arrangement passed by creditors of construction company Mercon, finding that the owners corporation of a 33-unit development has not proved the value of its $4.2 million claim. 
Abbey appeals failure in bid to invalidate patent for antiparasitic drug
Abbey Animal Health has appealed its loss in a suit seeking to invalidate rival Virbac's patent for an antiparasitic drug.
Abbey in ‘pyrrhic victory’ against Virbac over antiparasitic drug patent
Abbey Animal Health has managed only a “pyrrhic victory" in a patent case against rival Virbac over an antiparasitic drug, and must withdraw its Levamox Duo product from the market, a court has found.
Construction PRO
Dyldam directors on hook for $50M in case over alleged misuse of funds
Dyldam Developments' former boss Sam Fayad and his two sons have been ordered to pay over $50 million in a case by the liquidator of a special purpose vehicle claiming company funds were misused.
Construction PRO
Court hears of accounts ‘oddities’ as trial against Dyldam directors begins
A liquidator has opened his case over the alleged misuse of funds by now defunct Dyldam Developments, as the court hears of “oddities” in financial records and the spaghetti-like structure of 157 interrelated entities.